Yorktown Management & Research Company »

Halozyme Therapeutics shares owned by Yorktown Management & Research Company

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Yorktown Management & Research Company from 13F filings

Historical chart of Yorktown Management & Research Company investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Yorktown Management & Research Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Yorktown Management & Research Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $288k 4.5k 64.63

More positions owned by Yorktown Management & Research Company

Comfort Systems USA (FIX)
Ies Hldgs (IESC)
iShares Convertible Bond ETF Conv Bd Etf (ICVT)
SPDR Bloomberg Convertible Securities ETF State Street Spd (CWB)
Fabrinet SHS (FN)
Vanguard Emerging Markets Government Bond ETF Em Mk Gov Bd Etf (VWOB)
NOVA MEASURING Instruments L (NVMI)
Mueller Industries (MLI)
iShares iBoxx $ Investment Grade Corporate Bond Iboxx Inv Cp Etf (LQD)
Palo Alto Networks (PANW)
FTAI Aviation SHS (FTAI)
KLA Corporation Com New (KLAC)
Insmed Com Par $.01 (INSM)
Stonex Group (SNEX)
WESCO International (WCC)

View all positions for Yorktown Management & Research Company

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co

View all funds holding Halozyme Therapeutics